Rasmussen脑炎的临床、病理及治疗进展第一页,共四十三页
The2005EuropeanconsensusremainstheacceptedguidelineforevaluativecriteriaRasmussen’sencephalitis:clinicalfeatures,pathobiology,andtreatmentadvances
LancetNeurol2022;13:195–205第二页,共四十三页
Rasmussen脑炎〔RE〕临床特点•aprogressivedisease•drug-resistantfocalepilepsy•progressivehemiplegia〔偏瘫〕•cognitivedecline•withunihemispheric〔单侧半球〕brainatrophy第三页,共四十三页
流行病学•主要见于儿童,平均发病年龄6岁,婴幼儿到青年均可见•German:2-4casesper10millionpeopleaged18yearsandyoungerperyear•UK:anincidenceof1-7per10millionpeopleaged16yearsandyoungerperyear•性别、地理位置、种族等未见明显差异第四页,共四十三页
ThreediseasestagesRE•Prodromalstage:Non-specific,lowseizurefrequency,andmildhemiplegia•Acutestage:Frequentseizures,oftenepilepsiapartialiscontinua〔EPC〕;progressivehemiparesis,hemianopia〔偏盲〕,cognitivedeterioration,andaphasia〔失语〕(ifdominanthem